PCLO.V
Price:
$0.09
Market Cap:
$12.74M
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-03-04
Stock Exchange
TSXV
Ticker
PCLO.V
According to PharmaCielo Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -1.12. This represents a change of -56.27% compared to the average of -2.56 of the last 4 quarters.
The mean historical PE Ratio of PharmaCielo Ltd. over the last ten years is -34.95. The current -1.12 PE Ratio has changed 220.46% with respect to the historical average. Over the past ten years (40 quarters), PCLO.V's PE Ratio was at its highest in in the December 2023 quarter at -1.17. The PE Ratio was at its lowest in in the November 2017 quarter at -68.57.
Average
-34.95
Median
-5.30
Minimum
-214.71
Maximum
-1.65
Discovering the peaks and valleys of PharmaCielo Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 13.24%
Maximum Annual PE Ratio = -1.65
Minimum Annual Increase = -96.52%
Minimum Annual PE Ratio = -214.71
Year | PE Ratio | Change |
---|---|---|
2023 | -1.77 | 7.32% |
2022 | -1.65 | -68.93% |
2021 | -5.30 | 0.26% |
2020 | -5.29 | -37.50% |
2019 | -8.46 | 13.24% |
2018 | -7.47 | -96.52% |
The current PE Ratio of PharmaCielo Ltd. (PCLO.V) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.91
5-year avg
-4.49
10-year avg
-34.95
PharmaCielo Ltd.’s PE Ratio is less than Khiron Life Sciences Corp. (-0.20), greater than Blueberries Medical Corp. (-4.65), less than Charlotte's Web Holdings, Inc. (-0.55), greater than Cresco Labs Inc. (-3.09), greater than Curaleaf Holdings, Inc. (-5.66),
Company | PE Ratio | Market cap |
---|---|---|
-0.20 | $9.30M | |
-4.65 | $5.99M | |
-0.55 | $33.86M | |
-3.09 | $957.28M | |
-5.66 | $4.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaCielo Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PharmaCielo Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PharmaCielo Ltd.'s PE Ratio?
How is the PE Ratio calculated for PharmaCielo Ltd. (PCLO.V)?
What is the highest PE Ratio for PharmaCielo Ltd. (PCLO.V)?
What is the 3-year average PE Ratio for PharmaCielo Ltd. (PCLO.V)?
What is the 5-year average PE Ratio for PharmaCielo Ltd. (PCLO.V)?
How does the current PE Ratio for PharmaCielo Ltd. (PCLO.V) compare to its historical average?